Clinical Trial Update: Safety Study of Ranibizumab Eye Injections to Treat Choroidal Neovascularization That Was Caused Other Than by Age-Related Macular Degeneration. [Phase 1]

View source ↗

Summary

Phase 1 safety study evaluating ranibizumab injections to treat choroidal neovascularization not caused by age-related macular degeneration. The study has compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Choroidal Neovascularization

Drugs mentioned

• Lucentis (ranibizumab)

Snippet

Sponsor: Ophthalmic Consultants of Boston | Conditions: Choroidal Neovascularization | Phase 1 | Status: COMPLETED